Investor Relations Corporate Profile Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. RECENT NEWS February 13, 2020 Evolus to Participate in 9th Annual SVB Leerink Global Healthcare Conference February 12, 2020 Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020 January 27, 2020 Positive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crow’s Feet Lines Published in Dermatologic Surgery View all EVENTS SVB Leerink Global Healthcare Conference Feb 26, 2020 at 3:30 PM EST Q4 2019 Evolus Earnings Conference Call Feb 25, 2020 at 8:00 AM EST Q3 2019 Evolus Earnings Conference Call Nov 4, 2019 at 8:00 AM EST View all PRESENTATIONS January 2020 Investor Presentation Jan 10, 2020 May 2019 Evolus Investor and Analyst Day Presentation May 08, 2019 Aesthetic Surgery Journal Apr 08, 2019
February 12, 2020 Evolus to Report Fourth Quarter and Full Year 2019 Financial Results and Provide a Business Update on Tuesday, February 25, 2020
January 27, 2020 Positive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crow’s Feet Lines Published in Dermatologic Surgery